Trial intelligence / Profile preview

Prosigne vs Botox in Spasticity

NCT00819065Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Mar 2009
Primary completion
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Hospital de Clínicas de Porto Alegre. Started Mar 2009; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT00819065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00819065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call